SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
Adolescent
Adult
Bayes Theorem
COVID-19
/ epidemiology
Child
China
/ epidemiology
Contact Tracing
Family Characteristics
Female
Humans
Incidence
Male
Middle Aged
Quarantine
Retrospective Studies
Risk Assessment
Risk Factors
SARS-CoV-2
/ immunology
Seroepidemiologic Studies
Singapore
/ epidemiology
Young Adult
Journal
The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
13
08
2020
revised:
10
09
2020
accepted:
30
09
2020
pubmed:
6
11
2020
medline:
25
3
2021
entrez:
5
11
2020
Statut:
ppublish
Résumé
The proportion of asymptomatic carriers and transmission risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among household and non-household contacts remains unclear. In Singapore, extensive contact tracing by the Ministry of Health for every diagnosed COVID-19 case, and legally enforced quarantine and intensive health surveillance of close contacts provided a rare opportunity to determine asymptomatic attack rates and SARS-CoV-2 transmission risk factors among community close contacts of patients with COVID-19. This retrospective cohort study involved all close contacts of confirmed COVID-19 cases in Singapore, identified between Jan 23 and April 3, 2020. Household contacts were defined as individuals who shared a residence with the index COVID-19 case. Non-household close contacts were defined as those who had contact for at least 30 min within 2 m of the index case. All patients with COVID-19 in Singapore received inpatient treatment, with access restricted to health-care staff. All close contacts were quarantined for 14 days with thrice-daily symptom monitoring via telephone. Symptomatic contacts underwent PCR testing for SARS-CoV-2. Secondary clinical attack rates were derived from the prevalence of PCR-confirmed SARS-CoV-2 among close contacts. Consenting contacts underwent serology testing and detailed exposure risk assessment. Bayesian modelling was used to estimate the prevalence of missed diagnoses and asymptomatic SARS-CoV-2-positive cases. Univariable and multivariable logistic regression models were used to determine SARS-CoV-2 transmission risk factors. Between Jan 23 and April 3, 2020, 7770 close contacts (1863 household contacts, 2319 work contacts, and 3588 social contacts) linked to 1114 PCR-confirmed index cases were identified. Symptom-based PCR testing detected 188 COVID-19 cases, and 7582 close contacts completed quarantine without a positive SARS-CoV-2 PCR test. Among 7518 (96·8%) of the 7770 close contacts with complete data, the secondary clinical attack rate was 5·9% (95% CI 4·9-7·1) for 1779 household contacts, 1·3% (0·9-1·9) for 2231 work contacts, and 1·3% (1·0-1·7) for 3508 social contacts. Bayesian analysis of serology and symptom data obtained from 1150 close contacts (524 household contacts, 207 work contacts, and 419 social contacts) estimated that a symptom-based PCR-testing strategy missed 62% (95% credible interval 55-69) of COVID-19 diagnoses, and 36% (27-45) of individuals with SARS-CoV-2 infection were asymptomatic. Sharing a bedroom (multivariable odds ratio [OR] 5·38 [95% CI 1·82-15·84]; p=0·0023) and being spoken to by an index case for 30 min or longer (7·86 [3·86-16·02]; p<0·0001) were associated with SARS-CoV-2 transmission among household contacts. Among non-household contacts, exposure to more than one case (multivariable OR 3·92 [95% CI 2·07-7·40], p<0·0001), being spoken to by an index case for 30 min or longer (2·67 [1·21-5·88]; p=0·015), and sharing a vehicle with an index case (3·07 [1·55-6·08]; p=0·0013) were associated with SARS-CoV-2 transmission. Among both household and non-household contacts, indirect contact, meal sharing, and lavatory co-usage were not independently associated with SARS-CoV-2 transmission. Targeted community measures should include physical distancing and minimising verbal interactions. Testing of all household contacts, including asymptomatic individuals, is warranted. Ministry of Health of Singapore, National Research Foundation of Singapore, and National Natural Science Foundation of China.
Sections du résumé
BACKGROUND
The proportion of asymptomatic carriers and transmission risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among household and non-household contacts remains unclear. In Singapore, extensive contact tracing by the Ministry of Health for every diagnosed COVID-19 case, and legally enforced quarantine and intensive health surveillance of close contacts provided a rare opportunity to determine asymptomatic attack rates and SARS-CoV-2 transmission risk factors among community close contacts of patients with COVID-19.
METHODS
This retrospective cohort study involved all close contacts of confirmed COVID-19 cases in Singapore, identified between Jan 23 and April 3, 2020. Household contacts were defined as individuals who shared a residence with the index COVID-19 case. Non-household close contacts were defined as those who had contact for at least 30 min within 2 m of the index case. All patients with COVID-19 in Singapore received inpatient treatment, with access restricted to health-care staff. All close contacts were quarantined for 14 days with thrice-daily symptom monitoring via telephone. Symptomatic contacts underwent PCR testing for SARS-CoV-2. Secondary clinical attack rates were derived from the prevalence of PCR-confirmed SARS-CoV-2 among close contacts. Consenting contacts underwent serology testing and detailed exposure risk assessment. Bayesian modelling was used to estimate the prevalence of missed diagnoses and asymptomatic SARS-CoV-2-positive cases. Univariable and multivariable logistic regression models were used to determine SARS-CoV-2 transmission risk factors.
FINDINGS
Between Jan 23 and April 3, 2020, 7770 close contacts (1863 household contacts, 2319 work contacts, and 3588 social contacts) linked to 1114 PCR-confirmed index cases were identified. Symptom-based PCR testing detected 188 COVID-19 cases, and 7582 close contacts completed quarantine without a positive SARS-CoV-2 PCR test. Among 7518 (96·8%) of the 7770 close contacts with complete data, the secondary clinical attack rate was 5·9% (95% CI 4·9-7·1) for 1779 household contacts, 1·3% (0·9-1·9) for 2231 work contacts, and 1·3% (1·0-1·7) for 3508 social contacts. Bayesian analysis of serology and symptom data obtained from 1150 close contacts (524 household contacts, 207 work contacts, and 419 social contacts) estimated that a symptom-based PCR-testing strategy missed 62% (95% credible interval 55-69) of COVID-19 diagnoses, and 36% (27-45) of individuals with SARS-CoV-2 infection were asymptomatic. Sharing a bedroom (multivariable odds ratio [OR] 5·38 [95% CI 1·82-15·84]; p=0·0023) and being spoken to by an index case for 30 min or longer (7·86 [3·86-16·02]; p<0·0001) were associated with SARS-CoV-2 transmission among household contacts. Among non-household contacts, exposure to more than one case (multivariable OR 3·92 [95% CI 2·07-7·40], p<0·0001), being spoken to by an index case for 30 min or longer (2·67 [1·21-5·88]; p=0·015), and sharing a vehicle with an index case (3·07 [1·55-6·08]; p=0·0013) were associated with SARS-CoV-2 transmission. Among both household and non-household contacts, indirect contact, meal sharing, and lavatory co-usage were not independently associated with SARS-CoV-2 transmission.
INTERPRETATION
Targeted community measures should include physical distancing and minimising verbal interactions. Testing of all household contacts, including asymptomatic individuals, is warranted.
FUNDING
Ministry of Health of Singapore, National Research Foundation of Singapore, and National Natural Science Foundation of China.
Identifiants
pubmed: 33152271
pii: S1473-3099(20)30833-1
doi: 10.1016/S1473-3099(20)30833-1
pmc: PMC7831879
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
333-343Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311
pubmed: 32191691
BMJ Glob Health. 2020 May;5(5):
pubmed: 32467353
J Travel Med. 2020 May 18;27(3):
pubmed: 32297942
Nature. 2020 Sep;585(7825):410-413
pubmed: 32365354
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32603652
Lancet Infect Dis. 2020 Jul;20(7):809-815
pubmed: 32330439
Lancet. 2020 Mar 21;395(10228):947
pubmed: 32145187
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Clin Infect Dis. 2020 Dec 17;71(10):2679-2687
pubmed: 32497212
Lancet. 2020 May 16;395(10236):1541-1542
pubmed: 32423581
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
J Travel Med. 2020 May 18;27(3):
pubmed: 32167146
Clin Infect Dis. 2020 Jul 28;71(15):786-792
pubmed: 32211755
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
Nature. 2020 Aug;584(7820):262-267
pubmed: 32512578
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
Ann Intern Med. 2020 Dec 1;173(11):879-887
pubmed: 32790510